Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-26 Purchase |
2024-03-27 8:28 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
110,321 | $3.7263 | $411,094 | 570,814 (Indirect Direct) |
View |
| 2023-12-12 Purchase |
2023-12-13 5:11 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
5,000 | $2.07 | $10,350 | 25,384,293 (Indirect Direct) |
View |
| 2023-03-08 Purchase(A) |
2023-03-13 6:27 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-CEO & President |
23,527,044 | $1.05 | $24,703,396 | 9,884,095 (Indirect) |
View |
| 2023-03-08 Purchase |
2023-03-08 9:31 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
23,527,044 | $1.05 | $24,703,396 | 33,279,364 (Indirect Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:36 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Co-CEO & President |
5,809,132 | $0.97 | $5,634,858 | 3,495,435 (Indirect Direct) |
View |
| 2021-05-12 Purchase |
2021-05-14 4:37 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer |
389,077 | $5.24 | $2,038,763 | 4,747,860 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:12 pm |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
1,193 | $10.7 | $12,767 | 500,267 (Indirect Direct) |
View |
| 2020-06-17 Purchase |
2020-06-19 4:22 pm |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
7,950 | $7.01 | $55,730 | 499,074 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-08 Exercise |
2025-04-09 5:19 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer 10% Owner |
3,985,055 | $1.58 | 591,418,593 (Indirect) |
View |
| 2025-04-08 Exercise |
2025-04-09 5:19 pm |
2020-06-24 2029-12-24 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer 10% Owner |
3,985,055 | $0 | 591,418,593 (Indirect) |
View |
| 2025-01-24 Exercise |
2025-02-11 6:20 pm |
2024-07-03 2029-07-03 |
PULSE BIOSCIENCES INC. | PLSE | Zanganeh Mahkam Director |
60,242 | $0 | 873,469 (Direct) |
View |
| 2025-01-24 Exercise |
2025-02-11 6:20 pm |
N/A N/A |
PULSE BIOSCIENCES INC. | PLSE | Zanganeh Mahkam Director |
60,242 | $11 | 873,469 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:39 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer 10% Owner |
10,724 | $9.18 | 591,503,862 (Indirect) |
View |
| 2024-10-03 Exercise |
2024-10-03 4:54 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
315,681 | $1.58 | 35,738,442 (Indirect) |
View |
| 2024-10-03 Exercise |
2024-10-03 4:54 pm |
2020-06-24 2029-12-24 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
315,681 | $0 | 35,738,442 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 7:29 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
44,052 | $22.7 | 35,422,761 (Indirect) |
View |
| 2024-08-23 Option Award |
2024-08-23 4:42 pm |
N/A 2032-06-28 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
2,757,640 | $0 | 2,757,640 (Direct) |
View |
| 2024-08-09 Option Award |
2024-08-13 6:50 pm |
N/A 2034-08-09 |
PULSE BIOSCIENCES INC. | PLSE | Zanganeh Mahkam Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-07-03 Exercise |
2024-07-09 09:20 am |
N/A N/A |
PULSE BIOSCIENCES INC. | PLSE | Zanganeh Mahkam Director |
60,242 | $0 | 873,469 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-24 7:40 pm |
N/A 2034-06-06 |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
28,247 | $0 | 28,247 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 5:11 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
315,681 | $1.58 | 25,384,293 (Indirect) |
View |
| 2023-12-11 Exercise |
2023-12-13 5:11 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
489,814 | $1.44 | 25,384,293 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 5:11 pm |
2023-12-11 2025-06-30 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
805,495 | $0 | 25,384,293 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-15 5:37 pm |
N/A 2032-05-19 |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
76,075 | $0 | 752,985 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-15 5:37 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
76,075 | $2.14 | 752,985 (Direct) |
View |
| 2023-10-13 Option Award |
2023-10-16 4:08 pm |
N/A 2033-10-13 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
11,988,198 | $0 | 11,988,198 (Direct) |
View |
| 2023-06-09 Exercise(A) |
2023-07-06 8:30 pm |
2022-06-09 2027-06-09 |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
86,668 | $0 | 676,910 (Direct) |
View |
| 2023-06-09 Exercise(A) |
2023-07-06 8:30 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
86,668 | $2.05 | 676,910 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-13 5:26 pm |
2022-06-09 2027-06-09 |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
86,668 | $0 | 939,989 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-13 5:26 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
86,668 | $2.05 | 939,989 (Direct) |
View |
| 2023-05-25 Option Award |
2023-06-06 7:28 pm |
N/A 2033-05-25 |
Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director |
40,168 | $0 | 40,168 (Direct) |
View |
| 2022-12-06 Other |
2022-12-09 6:22 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-CEO & President |
373,857 | $0 | 11,304,706 (Direct) |
View |
| 2022-06-09 Exercise |
2022-06-10 6:59 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
86,668 | $0 | 676,910 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-23 8:52 pm |
N/A 2032-05-19 |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
76,075 | $0 | 76,075 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:16 pm |
N/A 2031-12-15 |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-21 5:09 pm |
2021-06-20 2031-05-20 |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
28,026 | $0 | 28,026 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-21 4:32 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
3,307 | $7.01 | 503,574 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-21 4:32 pm |
2020-06-15 2025-06-15 |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
3,307 | $0 | 503,574 (Direct) |
View |
| 2020-11-22 Option Award |
2020-11-24 6:12 pm |
2021-11-22 2030-11-22 |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer |
2,400,000 | $0 | 8,083,282 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-13 5:25 pm |
2021-11-11 2030-11-11 |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Director |
203,323 | $0 | 7,004,460 (Direct) |
View |
Ownership |
2020-11-13 5:20 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Director |
0 | $0 | 5,479,960 (Indirect) |
View |
| 2020-06-15 Exercise |
2020-06-17 4:09 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
22,050 | $7.01 | 494,431 (Direct) |
View |
| 2020-05-18 Option Award |
2020-05-19 6:26 pm |
2020-06-18 2030-05-18 |
Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director |
34,071 | $0 | 34,071 (Direct) |
View |